In addition, in fibrous dysplasia, a clinical condition in which activating Gsα mutations cause elevated cAMP levels, increased osteoclasts occur primarily in response to osteoblast secretion of interleukin-612, 13. The gene discussed is GNAS; the disease is fibrous dysplasia.